Recent analyst upgrades have fueled Palantir's momentum, with Goldman Sachs raising its rating to Buy and a $230 target, followed by Barclays initiating Overweight coverage at $265. These moves coincide with the stock's surge to an all-time high near $209 on October 9, driven by 93% year-over-year revenue growth in Q2 2026, 149% U.S. commercial expansion, and raised full-year guidance to approximately 82% growth. High operating margins above 47% and sovereign AI tailwinds support the bullish case, though elevated valuation multiples near 170x trailing earnings introduce downside risk if momentum fades. The November 2 earnings release remains a key near-term catalyst that could clarify whether the rally extends or triggers profit-taking.